-
November 2026
On 24 November 2026 the World Dementia Council holds a virtual dialogue, The New Patient, with speakers Aaron Daniels (Alzheimer’s Association) and Chris Lynch (Alzheimer’s Disease International). New treatments and ways of diagnosing dementia mean people are diagnosed earlier, sometimes before symptoms. The dialogue will explore what this means for diagnosis, care and support.
-
December 2026
On 1 December 2026 the World Dementia Council holds the Global Advocacy Leaders Exchange, a virtual meeting of leaders of advocacy organisations from around the world. With treatments arriving and diagnosis advancing, the exchange will explore how advocacy movements are making the case for health systems to adopt biomarkers.
-
December 2026
On 4 December 2026 the World Dementia Council holds a virtual dialogue, Experience of Treatments, on early lessons from delivering the first Alzheimer’s treatments. Chaired by Dr Heather Snyder (Alzheimer’s Association), it opens with Dr Jared Brosch (Indiana University School of Medicine), Professor Atsushi Iwata (Tokyo Metropolitan Institute for Geriatrics and Gerontology) and Professor Frank Jessen (University of Cologne).
-
July 2026
The AAIC Advocacy Breakfast, held by the World Dementia Council and the Alzheimer’s Association alongside AAIC in London on 15 July 2026, explored what it will take to turn scientific progress into change for patients, and how advances in diagnosis and treatment can reach clinics and health systems worldwide.
-
June 2026
Treatments in Europe, a virtual roundtable on 24 June 2026, asked how Alzheimer’s treatments are adopted. Chaired by Hilary Evans-Newton (Alzheimer’s Research UK), it heard from Lorène Gilly (France Alzheimer), Professor Linus Jönsson (Karolinska Institutet) and David Thomas (Alzheimer’s Research UK) on why regulators have approved the first therapies but payers have yet to follow.
-
April 2026
Advancing Advocacy, a breakfast roundtable at the ADI Conference in Lyon on 15 April 2026, explored how advocacy must change as dementia enters an era of biomarkers, earlier diagnosis and the first disease-modifying treatments, and what it means for movements built around carers to engage people at the earliest stages.
-
April 2026
Biomarker Implementation, a virtual dialogue on 9 April 2026, examined how blood-based biomarkers can move from research into health systems. Chaired by Dr Fiona Carragher (Alzheimer’s Society), it heard from Professor Jeff Burns (University of Kansas), Dr Argonde van Harten (Alzheimer Center Amsterdam), Dr Mark McClellan (Duke University) and Dr Vanessa Raymont (University of Oxford) on the challenges of adoption.
-
January 2026
Brain Health Advocacy, a virtual dialogue on 27 January 2026, examined how brain health works as a public policy idea. Chaired by Robert Egge (Alzheimer’s Association), it heard from Dr Harris Eyre (Global Brain Economy Initiative), Fred Destrebecq (European Brain Council) and Professor Giovanni Frisoni (Geneva University) on where the story works and where it needs clearer definition.
-
December 2025
Advocacy Leaders, a private virtual dialogue on 10 December 2025, brought together leaders from not-for-profits, academia and industry to consider priorities for advocacy in an era of earlier diagnosis, prevention and new treatments, and how advocacy can help turn scientific progress into real change for people and communities.
-
October 2025
At the Alzheimer Europe Conference in Bologna on 7 October 2025, the World Dementia Council hosted a panel on advancing advocacy in an era of treatments. It looked at three priorities: brain health strategies, bringing diagnostics and treatments into routine care, and changing the public story about dementia.
-
September 2025
Advancing Brain Health, a dinner hosted by the World Dementia Council in New York on 22 September 2025 during UNGA, launched a year-long programme on public policy for brain health. It brought together people working in brain health, from academia to advocacy, to share ideas on how to drive policy forward worldwide.
-
July 2025
The AAIC Advocacy Breakfast, held by the World Dementia Council and the Alzheimer’s Association at AAIC in Toronto on 30 July 2025, explored what it takes to turn scientific progress into meaningful change on the ground, and how advocacy can help drive the move from discovery to delivery.